title: Leflunomide as an antiatherogenic drug.
authors.forename: Piercarlo
authors.initials: P
authors.lastname: Minoretti
authors.forename: Anna
authors.initials: A
authors.lastname: Bruno
authors.forename: Clara
authors.initials: C
authors.lastname: Di Vito
authors.forename: Enzo
authors.initials: E
authors.lastname: Emanuele
mesh_terms: D000938:Antigen-Presenting Cells / Q000187:drug effects; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy*; D002633:Chemotaxis / Q000187:drug effects; D003713:Dendritic Cells / Q000187:drug effects; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D007963:Leukocytes, Mononuclear / Q000187:drug effects; D008955:Models, Cardiovascular; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D018501:Antirheumatic Agents; D007555:Isoxazoles; D016328:NF-kappa B; D000077339:Leflunomide